Ajan Reginald: Biotech Entrepreneur
Roquefort Therapeutics (LSE: ROQ, QTCQB: ROQAF) (Roquefort) is an LSE main-market-listed BioTech company exploring the high-value and high-growth oncology market. We at Colitco secured an exclusive interview with Ajan Reginald, CEO of Roquefort Therapeutics. Q: Ajan Reginald, thank you for agreeing to give Colitco an exclusive. Before we get into Roquefort Therapeutics and your company’s …